What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
His primary areas of study are Visceral leishmaniasis, Leishmaniasis, Immunology, Leishmania donovani and Miltefosine.
His studies in Visceral leishmaniasis integrate themes in fields like Surgery, Internal medicine, Adverse effect, Combination therapy and Intensive care medicine.
His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Chemotherapy, Nephrotoxicity, Oral administration and Indian visceral leishmaniasis.
His Leishmaniasis research is multidisciplinary, incorporating elements of Clinical trial, Pharmacology, Veterinary medicine, Leishmania and Drug resistance.
The concepts of his Leishmania donovani study are interwoven with issues in Incidence, Virology, Amastigote, Microbiology and Molecular biology.
His research in Miltefosine focuses on subjects like Dermatology, which are connected to Cutaneous leishmaniasis.
His most cited work include:
- Drug Resistance in Leishmaniasis (1224 citations)
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (1139 citations)
- Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda (636 citations)
What are the main themes of his work throughout his whole career to date?
Shyam Sundar mainly investigates Visceral leishmaniasis, Leishmaniasis, Leishmania donovani, Immunology and Internal medicine.
His Visceral leishmaniasis research is mostly focused on the topic Miltefosine.
His study in Leishmaniasis is interdisciplinary in nature, drawing from both Chemotherapy, Serology, Direct agglutination test, Intensive care medicine and Veterinary medicine.
Shyam Sundar interconnects Molecular biology, Amastigote and Drug resistance, Microbiology in the investigation of issues within Leishmania donovani.
His work carried out in the field of Immunology brings together such families of science as Peripheral blood mononuclear cell and Asymptomatic.
His research combines Gastroenterology and Internal medicine.
He most often published in these fields:
- Visceral leishmaniasis (54.77%)
- Leishmaniasis (33.08%)
- Leishmania donovani (31.38%)
What were the highlights of his more recent work (between 2017-2021)?
- Visceral leishmaniasis (54.77%)
- Leishmania donovani (31.38%)
- Leishmaniasis (33.08%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Visceral leishmaniasis, Leishmania donovani, Leishmaniasis, Immunology and Leishmania.
His study in the field of Miltefosine is also linked to topics like Indian subcontinent.
His Leishmania donovani study combines topics in areas such as Immunity, Antigen, Microbiology, Intracellular and Pharmacology.
His Leishmaniasis research integrates issues from Xenodiagnosis, Intensive care medicine, Disease and Virology.
The Leishmania study combines topics in areas such as Macrophage and Proteomics, Gene, Genome.
His Internal medicine research is multidisciplinary, incorporating perspectives in Serology and Rapid diagnostic test.
Between 2017 and 2021, his most popular works were:
- Eliminating visceral leishmaniasis in South Asia: the road ahead. (37 citations)
- Current and emerging medications for the treatment of leishmaniasis (33 citations)
- Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani. (26 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
